Paola Sindaco

1.3k total citations
28 papers, 970 citations indexed

About

Paola Sindaco is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Paola Sindaco has authored 28 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Paola Sindaco's work include Diabetes Management and Research (14 papers), Diabetes Treatment and Management (12 papers) and Lymphoma Diagnosis and Treatment (6 papers). Paola Sindaco is often cited by papers focused on Diabetes Management and Research (14 papers), Diabetes Treatment and Management (12 papers) and Lymphoma Diagnosis and Treatment (6 papers). Paola Sindaco collaborates with scholars based in Italy, United States and Sweden. Paola Sindaco's co-authors include Simone Pampanelli, M. Ciofetta, Geremia B. Bolli, C. Lalli, P. Brunetti, Elisabetta Torlone, Paolo Brunetti, Mauro Lepore, G B Bolli and G. Perriello and has published in prestigious journals such as Diabetes Care, Diabetes and Scientific Reports.

In The Last Decade

Paola Sindaco

28 papers receiving 907 citations

Peers

Countries citing papers authored by Paola Sindaco

Since Specialization

Citations

This map shows the geographic impact of Paola Sindaco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paola Sindaco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paola Sindaco more than expected).

Fields of papers citing papers by Paola Sindaco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paola Sindaco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paola Sindaco. The network helps show where Paola Sindaco may publish in the future.

Co-authorship network of co-authors of Paola Sindaco

This figure shows the co-authorship network connecting the top 25 collaborators of Paola Sindaco. A scholar is included among the top collaborators of Paola Sindaco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paola Sindaco. Paola Sindaco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effectiveness, Simplification and Persistence of IDegLira in Poorly Controlled People with Type 2 Diabetes: A 4-Year Follow-Up Real-World Study 2024 ·Diabetes Therapy ·Chiara Di Loreto, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Paola Sindaco	5
2	XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53–p21 and p27 pathways 2024 ·Scientific Reports ·Nitin Chakravarti, (unknown), (unknown), Paola Sindaco, (unknown), Kathleen McConnell, Anjali Mishra, Pierluigi Porcu	10
3	Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms 2023 ·Blood Advances ·(unknown), W. Thomas Johnson, Kathleen McConnell, Ashley N. Vogel, Jonathan E. Brammer, (unknown), (unknown), Paola Sindaco, (unknown), Guldeep Uppal, Neda Nikbakht, Bruno Calabretta, Patrizia Porazzi, Jerald Z. Gong, Nitin Chakravarti, Pierluigi Porcu, Anjali Mishra	4
4	Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities 2023 ·Frontiers in Oncology ·(unknown), (unknown), Colin Thomas, Paola Sindaco, Alan Soo Beng Khoo, Pierluigi Porcu	6
5	The role of interleukin-15 in the development and treatment of hematological malignancies 2023 ·Frontiers in Immunology ·Paola Sindaco, (unknown), (unknown), Nitin Chakravarti, Jonathan E. Brammer, Pierluigi Porcu, Anjali Mishra	21
6	Effectiveness in Real World of Once Weekly Semaglutide in People with Type 2 Diabetes: Glucagon-Like Peptide Receptor Agonist Naïve or Switchers from Other Glucagon-Like Peptide Receptor Agonists: Results from a Retrospective Observational Study in Umbria 2022 ·Diabetes Therapy ·Chiara Di Loreto, (unknown), (unknown), (unknown), Paola Sindaco	19
7	Switching Patients with Type 1 Diabetes to Insulin Degludec from Other Basal Insulins: Real-World Data of Effectiveness and Safety 2019 ·Diabetes Therapy ·Paola Ponzani, Cesare Berra, (unknown), Paola Sindaco, Chiara Di Loreto, Francesco Reggiani, Giuseppe Lucisano, Maria Chiara Rossi	5
8	Extralymphatic Disease Is an Independent Prognostic Factor in Hodgkin Lymphoma 2018 ·Clinical Lymphoma Myeloma & Leukemia ·Francesco Gaudio, (unknown), Artor Niccoli Asabella, Tommasina Perrone, (unknown), Paola Sindaco, (unknown), (unknown), Angela Pezzolla, Giuseppe Rubini, Giorgina Specchia	4
9	Bone Involvement in Hodgkin’s Lymphoma: Clinical Features and Outcome 2018 ·Acta Haematologica ·Francesco Gaudio, (unknown), Artor Niccoli Asabella, Giuseppe Ingravallo, Paola Sindaco, (unknown), Tommasina Perrone, (unknown), Giuseppe Rubini, Amato Antonio Stabile Ianora, Giorgina Specchia	11
10	Impact of Insulin Degludec in Type 2 Diabetes: Real-World Data on Effectiveness and Safety 2018 ·Diabetes Therapy ·Paola Ponzani, Cesare Berra, (unknown), Paola Sindaco, Chiara Di Loreto, Francesco Reggiani, Giuseppe Lucisano, Maria Chiara Rossi	7
11	Effects of vitamin C and aspirin in ischemic stroke‐related lipid peroxidation: Results of the AVASAS (Aspirin Versus Ascorbic acid plus Aspirin in Stroke) Study 2005 ·BioFactors ·Maria Cristina Polidori, Domenico Praticò, Tiziana Ingegni, Elena Mariani, Liana Spazzafumo, Paola Sindaco, Roberta Cecchetti, Yuemang Yao, Stefano Ricci, Antonio Cherubini, Wilhelm Stahl, Helmut Sies, Umberto Senin, Patrizia Mecocci, (unknown)	23
12	Lack of association of human chemokine receptor gene polymorphisms CCR2‐64I and CCR5‐Δ32 with autoimmune Addison's disease 2004 ·European Journal of Immunogenetics ·Giovanni Gambelunghe, Mehran Ghaderi, Baback Gharizadeh, Annalisa Brozzetti, (unknown), Paola Sindaco, Carani B. Sanjeevi, Peter Hjelmström, Allan Sirsjö, P. Nyrén, Fausto Santeusanio, A Falorni	7
13	Lack of association of CCR2–64I and CCR5-Δ32 with type 1 diabetes and latent autoimmune diabetes in adults 2003 ·Human Immunology ·Giovanni Gambelunghe, Mehran Ghaderi, Annalisa Brozzetti, Paola Sindaco, (unknown), P. Nyrén, Peter Hjelmström, Liene Ņikitina-Zaķe, Carani B. Sanjeevi, Alberto Falorni	13
14	Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime. 1999 ·Diabetes Care ·M. Ciofetta, C. Lalli, Paola Sindaco, E. Torlone, Simone Pampanelli, (unknown), (unknown), P. Brunetti, G B Bolli	76
15	Use of the short-acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal 1998 ·Diabetic Medicine ·Paola Sindaco, M. Ciofetta, C. Lalli, G. Perriello, Simone Pampanelli, Elisabetta Torlone, P. Brunetti, Geremia B. Bolli	81
16	Late post-prandial hypoglycaemia as the sole presenting feature of secreting pancreatic β-cell adenoma in a subtotally gastrectomized patient 1997 ·European Journal of Endocrinology ·Paola Sindaco, G Casucci, Simone Pampanelli, Kenneth S. Polonsky, Carmine G. Fanelli, Elisabetta Torlone, Fausto Santeusanio, Paolo Brunetti, Geremia B. Bolli	2
17	Contribution of Autonomic Neuropathy to Reduced Plasma Adrenaline Responses to Hypoglycemia in IDDM: Evidence for a Nonselective Defect 1997 ·Diabetes ·Paolo Bottini, Enrico Boschetti, Simone Pampanelli, M. Ciofetta, Paola Sindaco, L. Scionti, Paolo Brunetti, Geremia B. Bolli	71
18	Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia 1996 ·Diabetologia ·Simone Pampanelli, Carmine G. Fanelli, C. Lalli, M. Ciofetta, Paola Sindaco, Mauro Lepore, F. Modarelli, A. M. Rambotti, L. Epifano, Angelo Di Vincenzo, Luca Bartocci, Bruno Annibale, P. Brunetti, Geremia B. Bolli	46
19	Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans 1994 ·Diabetologia ·Carmine G. Fanelli, Simone Pampanelli, L. Epifano, A. M. Rambotti, M. Ciofetta, F. Modarelli, Angelo Di Vincenzo, Bruno Annibale, Mauro Lepore, C. Lalli, Paola Sindaco, P. Brunetti, Geremia B. Bolli	135
20	Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans 1994 ·Diabetologia ·Carmine G. Fanelli, Simone Pampanelli, L. Epifano, A. M. Rambotti, Angelo Di Vincenzo, Bruno Annibale, Mauro Lepore, C. Lalli, Paola Sindaco, P. Brunetti, G. B. Bolli, M. Ciofetta, F. Modarelli	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact